期刊文献+

环氧化酶-2启动子区基因单核苷酸多态性与老年人阿司匹林抵抗的关系 被引量:9

Relationship between single nucleotide polymorphisms in promoter region of cyclooxygenase-2 gene and aspirin resistance in the elderly
暂未订购
导出
摘要 目的研究环氧化酶-2(COX-2)基因启动子765G>C、1195G>A和1290A>G的单核苷酸多态性(SNP)与老年人发生阿司匹林抵抗的关系。方法以162例服用阿司匹林进行抗血栓治疗的老年患者为研究对象,行血小板聚集检测,根据检测结果分组并分析阿司匹林抵抗发生的危险因素。采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)技术对COX-2基因启动子765G>C、1195G>A和1290A>G的单核苷酸多态性进行分析。结果根据血小板聚集检测结果,阿司匹林敏感组108例,非阿司匹林敏感组54例。多元逐步Logistic回归分析显示高血压为阿司匹林抵抗发生的独立危险因素。两组间-765G>C SNP位点基因型及等位基因频率分布的差异有统计学意义(P=0.027和P=0.030);Logistic回归分析显示:与-765GG纯合基因携带者相比,-765GC杂合基因携带者对阿司匹林药效不敏感的OR值为3.872(95%CI 1.081~13.870,P=0.038)。两组间-1195G>A SNP位点基因型分布差异有统计学意义(P=0.018),其A、G等位基因频率的差异无统计学意义(P=0.156)。两组间-1290A>G SNP位点基因型分布差异无统计学意义(P=0.091),其A、G等位基因频率分布差异有统计学意义(P=0.025)。阿司匹林非敏感组等位基因-765G>C、-1195G>A和-1290A>G呈单倍型C-G-G的出现频率明显高于阿司匹林敏感组(P<0.05)。结论 -765G>C、-1195G>A和-1290A>G呈单倍型C-G-G与阿司匹林抵抗的发生可能有一定关系,-765G>C基因多态性可能是老年患者发生阿司匹林抵抗的遗传性危险因素。 Objective To explore the relationship between 765GC,1195GA and 1290AG single nucleotide polymorphisms(SNP) in the promoter region of cyclooxygenase-2(COX-2) gene and aspirin resistance in the elderly.Methods One hundred and sixty-two elder patients taking aspirin for antithrombotic therapy were selected,platelet aggregation tests were performed,groups were divided according to test findings,and risk factors of aspirin resistance were analysed.Polymerase chain reaction-restriction fragment length polymorphism(PCR-RFLP) was employed to analyse 765GC,1195GA and 1290AG SNP in the promoter region of COX-2 gene.Results Patients were divided into aspirin sensitive group(n=108) and non-aspirin sensitive group(n=54).Multiple stepwise Logistic regression analysis indicated that hypertension was an independent risk factor of aspirin resistance.There were significant differences in the genotype distribution and allele frequency of-765GC SNP between two groups(P=0.027,P=0.030).Logistic regression analysis demonstrated that compared with-765GG genotype,OR of aspirin resistance for-765GC genotype was 3.872(95% CI 1.081-13.870,P=0.038).There were significant differences in genotype distribution of-1195GA SNP between two groups(P=0.018),and there was no significant difference in allele frequencies of A and G between them(P=0.156).There was no significant difference in genotype distribution of-1290AG SNP between two groups(P=0.091),and there were significant differences in allele frequencies of A and G between them(P=0.025).The frequency of haplotype C-G-G of-765GC,-1195GA and-1290AG in non-aspirin sensitive group was significantly higher than that in aspirin sensitive group(P0.05).Conclusion Haplotype C-G-G of-765GC,-1195GA and-1290AG may be related to aspirin resistance,and-765GC gene polymorphisms may be genetic risk factor of aspirin resistance for elder patients.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2012年第3期301-306,共6页 Journal of Shanghai Jiao tong University:Medical Science
基金 上海市教委基金(11YZ57)~~
关键词 环氧化酶-2 阿司匹林抵抗 单核苷酸多态性 单倍型 cyclooxygenase-2 aspirin resistance single nucleotide polymorphism haplotype
  • 相关文献

参考文献4

二级参考文献18

  • 1Yong Yong SHI,Lin HE.SHEsis,a powerful software platform for analyses of linkage disequilibrium,haplotype construction,and genetic association at polymorphism loci[J].Cell Research,2005,15(2):97-98. 被引量:394
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33093
  • 3Faraday N, Yanek LR, Mathias R, et al. Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1 [J]. Circulation, 2007, 115(19):2490-2496.
  • 4Maree AO, Curtin RJ, Chubb A, et al. Cyclooxygenase-1 haplotype modulates platelet response to aspirin [J]. J Thromb Haemost, 2005, 3(10):2340-2345.
  • 5Gonzalez-Conejero R, Rivera J, Corral J, et al. Biological assessment of aspirin efficacy on healthy individuals: heterogeneous response or aspirin failure? [J]. Stroke, 2005, 36(2):276-280.
  • 6Hillarp A, Palmqvist B, Lethagen S, et al. Mutations within the cyclooxygenase-1 gene in aspirin non- responders with recurrence of stroke [J]. Thromb Res, 2003, 112(5-6):275-283.
  • 7Takahashi S, Ushida M, Komine R, et al. Platelet responsiveness to in vitro aspirin is independent of COX- 1 and COX-2 protein levels and polymorphisms [J]. Thromb Res, 2008, 121(4): 509-517.
  • 8Li Q, Chen BL, Ozdemir V, et al. Frequency of genetic polymorphisms of COX1, GPIIIa and P2Y1 in a Chinese population and association with attenuated response to aspirin[J]. Pharmacogenomics, 2007, 8(6):577-586.
  • 9Cambria-Kiely JA, Gandhi PJ. Aspirin resistance and genetic polymorphisms[J]. J Thromb Thrombolysis, 2002, 14(1):51-58.
  • 10Dropinski J, Musial J, Sanak M, et al. Antithrombotic effects of aspirin based on PLA1/A2 glycoprotein IIIa polymorphism in patients with coronary artery disease[J]. Thromb Res, 2007, 119(3):301-303.

共引文献468

同被引文献79

  • 1赵勇,王建春,孙慧,王传霞,李元堂,尹承华,张杰,邵建华.环氧化酶-2基因-765G>C多态性与老年代谢综合征患者阿司匹林抵抗无关[J].中国分子心脏病学杂志,2011,11(3):164-168. 被引量:4
  • 2张远飞,温绍昌.阿司匹林抵抗机制的研究[J].云南医药,2013,34(3):265-268. 被引量:1
  • 3中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中国医学前沿杂志(电子版),2010,2(4):50-59. 被引量:1982
  • 4苏冠华,王朝晖,丁艳萍,刘晓倩.血小板膜糖蛋白Ⅰ a807C/T多态性与阿司匹林抵抗的关系[J].中国血液流变学杂志,2007,17(1):43-45. 被引量:8
  • 5Antithrombotic Trialists1 Collaboration.Collabo-rative meta-analysis of randomised trials of an-tiplatelet therapy for prevention of death,myocardialinfarction,and stroke in high risk patients[J].BMJ,2002,324:71-86.
  • 6McKee SA,Sane DC,Deliargyris EN.Aspirin re-sistance in cardiovascular disease:a review of preva-lence,mechanisms,and clinical significance[J].Thromb Haemost,2002,88:711-715.
  • 7Zheng AS,Churilov L,Colley RE,et al.Associa-tion of aspirin resistance with increased stroke severityand infarct size[J].JAMA Neurol,2013,70:208-213.
  • 8O'Donnell CJ,Larson MG,Feng D,et al.Geneticand environmental contributions to platelet aggrega-tion:the Framingham heart study[J].Circulation,2001,103:3051-3056.
  • 9Sharma V,Kaul S,Al-Hazzani A,et al.Associa-tion of COX-2 rs20417 with aspirin resistance[J].JThromb Thrombolysis,2013,35:95-99.
  • 10Gum PA,Kottke-Marchant K,Poggio ED,et al.Profile and prevalence of aspirin resistance in patientswith cardiovascular disease[J].Am J Cardiol,2001,88:230-235.

引证文献9

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部